Table 1.

Clinical information of patients with apoptosis-proficient and apoptosis-resistant ALL tumors


ALL

Age at diagnosis, y

WBC count at diagnosis, × 109/L

Length of first CR, mo

Clinical outcome

Prognostic cytogenetic abnormality
Apoptosis-proficient      
    32   12   210   56   CR   —  
    33   7   195   10   R   —  
    69   4   19   11   CR   Hyperdiploid (55)  
    70   6   56   11   Regimen change   —  
    74   2   7   62   CR   Hyperdiploid (55)  
    12   4   96   19   R   —  
    2   7   49   41   CR   t(12;21)  
    72   3   16   8   CR   Hyperdiploid (58-59)  
    90   2   11   0   CR   Hyperdiploid (56)  
    91   7   7   4   CR   Hyperdiploid (57)  
    92   6   47   0   CR   t(12;21)  
    86   11   4   1   D   Hyperdiploid (55)  
    88   5   6   1   CR   —  
    76   5   8   36   CR   TEL-AML ×2  
    17   3   12   34   CR   t(12;21)  
    75   9   330   7   CR   —  
    71   2   37   24   CR   Hyperdiploid (54-56)  
    34r   3   41   65   R   Hyperdiploid (58)  
    42r   3   68   33   R   —  
    89r   15   3   35   R   Hyperdiploid (53)  
    21r   15   55   9   R   —  
Apoptosis-resistant (normal p53 response)      
    20   18   118   42   CR (BMT as standard)   —  
    24   4   15   28   Regimen change   TEL-AML 1(complex translocation)  
    53   12   106   11   R   —  
    9   10   6   56   CR   t(12;21)  
    27   15   13   59   CR   t(1;19)  
    78   15   18   9   CR   t(12;21)  
    79   4   8   25   R   —  
    82   3   6   5   CR   Hyperdiploid (50)  
    84   7   21   7   CR   —  
    85   14   202   4   CR   —  
    93   5   3   1   CR   —  
    80r   3   35   41   R   t(12;21)  
    81r   4   18   72   R   Hyperdiploid (56)  
    36r   8   20   43   R   t(1;19)  
    83r   4   237   19   R   Hyperdiploid (53)  
Apoptosis-resistant (defective p53 response)      
    19*  13   69   16   R and D   —  
    22  2   140   31   Regimen change   t(1;19)  
    77r  9   2   38   R   t(12;21)  
    87r
 
11
 
16
 
11
 
R
 
Near haploid (27)
 

ALL

Age at diagnosis, y

WBC count at diagnosis, × 109/L

Length of first CR, mo

Clinical outcome

Prognostic cytogenetic abnormality
Apoptosis-proficient      
    32   12   210   56   CR   —  
    33   7   195   10   R   —  
    69   4   19   11   CR   Hyperdiploid (55)  
    70   6   56   11   Regimen change   —  
    74   2   7   62   CR   Hyperdiploid (55)  
    12   4   96   19   R   —  
    2   7   49   41   CR   t(12;21)  
    72   3   16   8   CR   Hyperdiploid (58-59)  
    90   2   11   0   CR   Hyperdiploid (56)  
    91   7   7   4   CR   Hyperdiploid (57)  
    92   6   47   0   CR   t(12;21)  
    86   11   4   1   D   Hyperdiploid (55)  
    88   5   6   1   CR   —  
    76   5   8   36   CR   TEL-AML ×2  
    17   3   12   34   CR   t(12;21)  
    75   9   330   7   CR   —  
    71   2   37   24   CR   Hyperdiploid (54-56)  
    34r   3   41   65   R   Hyperdiploid (58)  
    42r   3   68   33   R   —  
    89r   15   3   35   R   Hyperdiploid (53)  
    21r   15   55   9   R   —  
Apoptosis-resistant (normal p53 response)      
    20   18   118   42   CR (BMT as standard)   —  
    24   4   15   28   Regimen change   TEL-AML 1(complex translocation)  
    53   12   106   11   R   —  
    9   10   6   56   CR   t(12;21)  
    27   15   13   59   CR   t(1;19)  
    78   15   18   9   CR   t(12;21)  
    79   4   8   25   R   —  
    82   3   6   5   CR   Hyperdiploid (50)  
    84   7   21   7   CR   —  
    85   14   202   4   CR   —  
    93   5   3   1   CR   —  
    80r   3   35   41   R   t(12;21)  
    81r   4   18   72   R   Hyperdiploid (56)  
    36r   8   20   43   R   t(1;19)  
    83r   4   237   19   R   Hyperdiploid (53)  
Apoptosis-resistant (defective p53 response)      
    19*  13   69   16   R and D   —  
    22  2   140   31   Regimen change   t(1;19)  
    77r  9   2   38   R   t(12;21)  
    87r
 
11
 
16
 
11
 
R
 
Near haploid (27)
 

Shown for each patient are age and WBC at diagnosis, length of first continuous remission (CR), clinical outcome (R, relapse; D, death), and prognostic cytogenetic abnormalities (—, absence of prognostic cytogenetic abnormality; number of chromosomes is given in parentheses alongside ploidy status).

*

TP53 mutant.

Defective activation of p53 (possible ATM inactivation).

Close Modal

or Create an Account

Close Modal
Close Modal